Powered by

Generation Bio Reports Third Quarter 2020 Business Updates and Financial Results

Nov 10, 2020 - GlobeNewswire
Board and Executive Moves-Event Announcements-Financial Results

CAMBRIDGE, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO) is an innovative genetic medicines company creating a new class of non-viral gene therapy. Today the company reported recent business highlights and third quarter financial results.

“2020 continues to be a year of progress and execution for Generation Bio as we advance our non-viral gene therapy approach,” said Geoff McDonough, M.D., president and chief executive officer of Generation Bio. “Des...